BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 21402479)

  • 1. Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer.
    Yang CF; Adil SM; Anderson KL; Meyerhoff RR; Turley RS; Hartwig MG; Harpole DH; Tong BC; Onaitis MW; D'Amico TA; Berry MF
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1607-13. PubMed ID: 26719403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of diffusing lung capacity before and after neoadjuvant concurrent chemoradiation on postoperative pulmonary complications among patients with stage IIIA/N2 non-small-cell lung cancer.
    Shin S; Choi YS; Jung JJ; Im Y; Shin SH; Kang D; Cho JH; Kim HK; Kim J; Zo JI; Shim YM; Park K; Ahn MJ; Ahn YC; Lee G; Cho J; Lee HY; Park HY
    Respir Res; 2020 Jan; 21(1):13. PubMed ID: 31924201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence/prognosis estimation using a molecularly positive surgical margin-based model calls for alternative curative strategies in pIIIA/N2 NSCLC.
    Li L; He K; Zhou T; Xu Y; Pang J; Yu Q; Gao Y; Shi H; Zhu H; Li M; Yu J; Yuan S
    Mol Oncol; 2024 Jun; 18(6):1649-1664. PubMed ID: 38327028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upfront surgery for stage IIIA/B non-small cell lung cancer: retrospective cohort study.
    Deng H; Liu J; Cai X; Jiang S; Lu W; Ai Q; Li J; Xiong S; Qin X; Liang W; He J
    BJS Open; 2024 Mar; 8(2):. PubMed ID: 38513281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple-induction treatment for locally advanced non-small cell lung cancer: a case report of pathological complete response.
    Werner RS; Lauk O; Tscherry G; Curioni-Fontecedro A; Höller S; Opitz I
    J Cardiothorac Surg; 2024 Apr; 19(1):207. PubMed ID: 38616248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemoradiotherapy or chemotherapy followed by surgery is superior to that followed by definitive chemoradiation or radiotherapy in stage IIIA (N2) nonsmall-cell lung cancer: a meta-analysis and system review.
    Xu XL; Dan L; Chen W; Zhu SM; Mao WM
    Onco Targets Ther; 2016; 9():845-53. PubMed ID: 26955282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factor Analysis of Morbidity and 90-Day Mortality of Curative Resection in Patients with Stage IIIA-N2 Non-Small Cell Lung Cancer after Induction Concurrent Chemoradiation Therapy.
    Jeong GH; Lee J; Jeon YJ; Park SY; Kim HK; Choi YS; Kim J; Shim YM; Cho JH
    J Chest Surg; 2024 Apr; ():. PubMed ID: 38584378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent N2 disease after neoadjuvant chemotherapy for non-small-cell lung cancer.
    Higgins KA; Chino JP; Ready N; Onaitis MW; Berry MF; D'Amico TA; Kelsey CR
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1175-9. PubMed ID: 22014344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of stereotactic body radiation therapy (SBRT) after surgery for stage III non-small cell lung cancer.
    Singh AK; Hennon M; Ma SJ; Demmy TL; Picone A; Dexter EU; Nwogu C; Attwood K; Tan W; Hermann GM; Fung-Kee-Fung S; Malhotra HK; Yendamuri S; Gomez-Suescun JA
    BMC Cancer; 2018 Nov; 18(1):1183. PubMed ID: 30497431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment-Related Predictive and Prognostic Factors in Trimodality Approach in Stage IIIA/N2 Non-Small Cell Lung Cancer.
    Jeremić B; Casas F; Dubinsky P; Gomez-Caamano A; Čihorić N; Videtic G; Igrutinovic I
    Front Oncol; 2018; 8():30. PubMed ID: 29527511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transition from thoracotomy to uniportal video-assisted thoracic surgery in non-small cell lung cancer-the Oslo experience.
    Aamodt H
    J Vis Surg; 2016; 2():111. PubMed ID: 29399497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of nodal micrometastases in patients with non-small cell lung cancer: time for reconsideration?
    Carretta A
    J Thorac Dis; 2016 Dec; 8(12):E1755-E1758. PubMed ID: 28149634
    [No Abstract]   [Full Text] [Related]  

  • 13. CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer.
    Si J; Zhang P; Tian D; Wang X; Ma Y; Zhang J; Wang L; Yang Y
    World J Surg Oncol; 2017 Jan; 15(1):34. PubMed ID: 28129775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocation of left inferior lobe pulmonary artery to the pulmonary artery trunk for central type non-small cell lung cancers.
    Sun Y; Yang Y; Chen Y; Pan X; Yang Y; Gao W; Zhao H; Shi J
    J Thorac Dis; 2016 May; 8(5):826-32. PubMed ID: 27162655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical results and long-term follow-up of T(4)-non-small cell lung cancer invading the left atrium or the intrapericardial base of the pulmonary veins.
    Stella F; Dell'Amore A; Caroli G; Dolci G; Cassanelli N; Luciano G; Davoli F; Bini A
    Interact Cardiovasc Thorac Surg; 2012 Apr; 14(4):415-9. PubMed ID: 22269143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery for patients with persistent pathological N2 IIIA stage in non-small-cell lung cancer after induction radio-chemotherapy: the microscopic seed of doubt.
    Meacci E; Cesario A; Cusumano G; Lococo F; D'Angelillo R; Dall'armi V; Margaritora S; Granone P
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):656-63. PubMed ID: 21402479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer.
    Takeda S; Maeda H; Okada T; Yamaguchi T; Nakagawa M; Yokota S; Sawabata N; Ohta M
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):184-9. PubMed ID: 16730452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
    van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
    J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.